Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 563

1.

Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis.

Gerlag DM, Haringman JJ, Smeets TJ, Zwinderman AH, Kraan MC, Laud PJ, Morgan S, Nash AF, Tak PP.

Arthritis Rheum. 2004 Dec;50(12):3783-91.

2.

Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis.

Haringman JJ, Gerlag DM, Zwinderman AH, Smeets TJ, Kraan MC, Baeten D, McInnes IB, Bresnihan B, Tak PP.

Ann Rheum Dis. 2005 Jun;64(6):834-8. Epub 2004 Dec 2.

3.

Intraarticular glucocorticoid treatment reduces inflammation in synovial cell infiltrations more efficiently than in synovial blood vessels.

af Klint E, Grundtman C, Engström M, Catrina AI, Makrygiannakis D, Klareskog L, Andersson U, Ulfgren AK.

Arthritis Rheum. 2005 Dec;52(12):3880-9.

4.
5.

Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation.

Vergunst CE, Gerlag DM, Dinant H, Schulz L, Vinkenoog M, Smeets TJ, Sanders ME, Reedquist KA, Tak PP.

Rheumatology (Oxford). 2007 Dec;46(12):1773-8. Epub 2007 Oct 27.

PMID:
17965442
6.

The effects of interferon-beta treatment of synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis.

Smeets TJ, Dayer JM, Kraan MC, Versendaal J, Chicheportiche R, Breedveld FC, Tak PP.

Arthritis Rheum. 2000 Feb;43(2):270-4.

7.

Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis.

Vos K, Thurlings RM, Wijbrandts CA, van Schaardenburg D, Gerlag DM, Tak PP.

Arthritis Rheum. 2007 Mar;56(3):772-8.

8.

Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response.

Thurlings RM, Vos K, Wijbrandts CA, Zwinderman AH, Gerlag DM, Tak PP.

Ann Rheum Dis. 2008 Jul;67(7):917-25. Epub 2007 Oct 26.

9.

Real-time quantitative PCR to detect changes in synovial gene expression in rheumatoid arthritis after corticosteroid treatment.

Gerlag DM, Boyle DL, Rosengren S, Nash T, Tak PP, Firestein GS.

Ann Rheum Dis. 2007 Apr;66(4):545-7. Epub 2006 Sep 19.

10.

Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients.

van der Pouw Kraan TC, Wijbrandts CA, van Baarsen LG, Rustenburg F, Baggen JM, Verweij CL, Tak PP.

Ann Rheum Dis. 2008 Apr;67(4):563-6. Epub 2007 Nov 27.

PMID:
18042642
12.
13.

A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissue.

van Kuijk AW, Gerlag DM, Vos K, Wolbink G, de Groot M, de Rie MA, Zwinderman AH, Dijkmans BA, Tak PP.

Ann Rheum Dis. 2009 Aug;68(8):1303-9. doi: 10.1136/ard.2008.091389. Epub 2008 Jul 22.

14.

A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis.

Haringman JJ, Gerlag DM, Smeets TJ, Baeten D, van den Bosch F, Bresnihan B, Breedveld FC, Dinant HJ, Legay F, Gram H, Loetscher P, Schmouder R, Woodworth T, Tak PP.

Arthritis Rheum. 2006 Aug;54(8):2387-92.

15.

Reliability of computerized image analysis for the evaluation of serial synovial biopsies in randomized controlled trials in rheumatoid arthritis.

Haringman JJ, Vinkenoog M, Gerlag DM, Smeets TJ, Zwinderman AH, Tak PP.

Arthritis Res Ther. 2005;7(4):R862-7. Epub 2005 May 12.

16.

Etanercept reduces synovitis as measured by magnetic resonance imaging in patients with active rheumatoid arthritis after only 6 weeks.

Lisbona MP, Maymo J, Perich J, Almirall M, Pérez-García C, Carbonell J.

J Rheumatol. 2008 Mar;35(3):394-7. Epub 2008 Jan 15.

PMID:
18203329
17.

Systemic TNF blockade does not modulate synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients--a prospective clinical study.

Sundberg E, Grundtman C, Af Klint E, Lindberg J, Ernestam S, Ulfgren AK, Harris HE, Andersson U.

Arthritis Res Ther. 2008;10(2):R33. doi: 10.1186/ar2387. Epub 2008 Mar 17.

18.

Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis.

Barrera P, Blom A, van Lent PL, van Bloois L, Beijnen JH, van Rooijen N, de Waal Malefijt MC, van de Putte LB, Storm G, van den Berg WB.

Arthritis Rheum. 2000 Sep;43(9):1951-9.

20.

Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.

Catrina AI, Trollmo C, af Klint E, Engstrom M, Lampa J, Hermansson Y, Klareskog L, Ulfgren AK.

Arthritis Rheum. 2005 Jan;52(1):61-72.

Supplemental Content

Support Center